A
$ Value
$0
Shares
105,000
Price
$0
Filed
Feb 20
Insider
Name
Vaknin Rachel
Title
Chief Financial Officer
CIK
0001923217
Roles
Officer
Transaction Details
Transaction Date
2026-02-18
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
105,000
Footnotes
The options vest as follows and in accordance with the terms of the Issuer's 2020 Omnibus Performance Award Plan, as amended (the "Plan"): (a) on August 18, 2026, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock, subject to acceleration or forfeiture pursuant to the terms of the Plan.
Filing Info
Vaknin Rachel's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-18 | MBOT | A | $0 |
Other Insiders at MBOT (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| Burell Scott R | — | — | 2026-04-01 |
|
Gadot Harel
Chairman, President and CEO
|
— | — | 2026-02-18 |
| Madden Martin J. | — | — | 2026-04-01 |
| Laxminarain Prattipati | — | — | 2026-04-01 |
| Stockburger Aileen Ptucha | — | — | 2026-04-01 |
| Wenderow Tal Baruch | — | — | 2026-04-01 |
|
Sharon Simon
General Manager, CTO
|
— | — | 2026-02-18 |
|
Diaz-Cartelle Juan
Chief Medical Officer
|
— | — | 2026-02-18 |
| Wilson David James | — | — | 2026-04-01 |